Dr. Albert A. Rizzo, American Lung Association, Newark, DE (USA)

This lecture will discuss the entry of electronic inhalation delivery systems into the U.S. markets and the consequences of misinformation, lax regulation, and a mixed public health message regarding harm reduction.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Understand the development and evolution of electronic inhalational drug delivery systems as they entered the U.S. markets;
  • Appreciate the concern over the youth epidemic of e-cigarettes in the U.S. and the E-cigarette and Vaping Associated Lung Illness (EVALI); and
  • Discuss the public health measures needed to help prevent the medical consequences of vaping devices.